Fabry-betegség: vizsgálatok itt: Argentína
1 of 2 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
- Where
- Buenos Aires, Rosario
- Életkor
- 18 év and over
- People
- 18 worldwide
- Run by
- GC Biopharma Corp
See details and how to joinNCT06858397